The Society for Cardiovascular Angiography and Interventions (SCAI) announced the late-breaking clinic al trial data presentations for it its upcoming 2014 Scientific Sessions, May 28-31, in Las Vegas. The late-breaking clinical trials will be presented Friday, May 30, from 2-3 p.m. PST. 


May 2, 2014 — Medtronic Inc. revealed new data demonstrating positive outcomes for extreme risk patients with severe aortic stenosis who were treated with the CoreValve system via alternative access approaches. The data were unveiled during a late-breaking clinical session at the 94th American Association for Thoracic Surgery (AATS) annual meeting.

May 2, 2014 — Terso Solutions Inc., a provider of automated inventory management solutions for healthcare and life science, announced that Endologix Inc. has partnered with them for a fully automated, on-site consignment inventory program. Endologix chose Terso for their proven track record with both RFID (radio frequency identification device) solutions for medical device inventory management and cold chain security.

May 1, 2014 — Government regulations and JCAHO (Joint Commission) certification are driving providers to make purchasing plans for dose monitoring solutions, and in discussions about these plans, two vendors are capturing the majority of providers' mindshare. This is according to the latest KLAS report, Radiology Dose Monitoring Solutions 2014: Provider Strategies in an Evolving Market.

May 1, 2014 — Nuance Communications announced the immediate availability of the Nuance PowerShare network, the industry’s largest cloud-based network for securely connecting healthcare professionals to share essential medical images and reports as simply as people exchange information using social networks. The PowerShare network promotes fully informed and connected physicians and patients who instantly view, share and collaborate while addressing patients’ healthcare needs.

Boston Scientific Corp. has launched the Promus Premier Everolimus-Eluting Platinum Chromium Coronary Stent System in Japan. This advanced drug-eluting stent (DES) technology system recently received Japan Ministry of Health, Labor and Welfare (MHLW) approval.

Volcano Corp. announced the commencement of its limited market release of its U.S. Food and Drug Administration (FDA) cleared and CE marked technology SyncVision, with cases being performed in the United States and Europe. 

Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now